The cellular neurobiology of depression
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Major depressive disorders, long considered to be of neurochemical origin, have recently been associated with impairments in signaling pathways that regulate neuroplasticity and cell survival. Agents designed to directly target molecules in these pathways may hold promise as new therapeutics for depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity that putatively mediates depressive symptoms (Drevets et al, 2002a), or by enhancing the expression of neurotrophic factors that protect medial network function from the effects of repeated stress (Manji et al, 2001).”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Manji et al, 2001
In the citing paper
“Somatic antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity which putatively mediates depressive symptoms (Drevets et al. 2002a) and the expression of neurotrophic/neuroprotective factors that preserve the function of the MPFC (Manji et al. 2001).”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Manji et al. 2001
In the citing paper
“Depression is often associated with elevated HPA axis activity and increased levels of glucocorticoids, as well as disruption of negative feedback mechanisms21–23.”
From Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (2016) · cites this paper as [22]
Citations
Cites
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · cited 1×
“However, the demonstration that neurogenesis occurs in the adult human brain into senescenc”
BackgroundThe Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332 · cited 1×
“Modest changes in this signaling cascade or in the levels of the Bcl-2 family of proteins (potentially due to genetic, illness or insult-related factors) could therefore profoundly affect cellular viabilit”
BackgroundGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“It is thus not altogether surprising that the Global Burden of Disease Study has identified MDDs among the leading causes of disability worldwide, and as illnesses likely to represent an increasingly greater health, societal and economic problem in the coming year”
BackgroundAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“Current research is examining the potential efficacy of antagonists of corticotropin-releasing factor (CRF), antiglucocorticoids and direct and indirect glutamate antagonist”
BackgroundSelf-citationChronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · cited 1×
“These studies demonstrate that chronic administration of different classes of antidepressants increases the proliferation and survival of new neuron”
BackgroundPsychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 1×
“Moreover, lithium also inhibits the activity of glycogen synthase kinase 3β (GSK-3β”
BackgroundThe Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · cited 1×
“have demonstrated that an important pathway involved in cell survival and plasticity, the cAMP–CREB cascade, is up-regulated by antidepressant treatmen”
BackgroundTHE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION
Kessler, R. C. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.191 · Cited by 2,111 · cited 1×
“Thus, although MDDs undoubtedly have a strong genetic basis, severe stressors have been associated with a substantial increase in risk for the onset of MDDs in susceptible individuals ( Table 3”
Background
Research works printed but not linked: 4
- Garlow, S.J., Musselman, D.L. & Nemeroff C.B. The Neurochemistry of Mood Disorders clinical studies. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 348–364 (Oxford Press, New York, 1999).
- Drevets, W.C., Gadde, K. & Krishnan, R. Neuroimaging studies of depression. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 394–418 (Oxford Press, New York, 1999).
- LeDoux, J.E. Emotion. in Handbook of Physiology—The Nervous System, Vol. V. (eds. Mills, J., Mountcastle, V.B., Plum, F. & Geiger, S.R.) 373–417 (Williams & Wilkins, Baltimore, 1987).
- Manji, H.K. et al. Regulation of signal transduction pathways by mood stabilizing agents: Implications for the pathophysiology and treatment of bipolar affective disorder. in Bipolar Medications: Mechanisms of Action. (eds. Manji, H.K., Bowden, C.L. & Belmaker, R.H.) 129–177 (American Psychiatric Press, Washington, DC, 2000).
Cited by
Items 701–800 of 1,000
Dzitoyeva, S., Imbesi, M., Uz, T., Dimitrijević, N., Manev, H., & Manev, R. M. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0034-7 · Cited by 23
“BDNF has been implied as a participating biological mechanism in depression and antidepressant activity (Groves 2007; Manji et al. 2001; Martinowich et al. 2007; Tardito et al. 2006).”
BackgroundTherapeutic Implications of microRNAs in Depressive Disorders: A Review
Hassan, M., Amir, A., Shahzadi, S., & Kloczkowski, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113530 · Cited by 24
Liu, X., Tang, S., Liu, S.-M., Zeng, J., Chen, Z., Liu, C.-H., Mu, R.-H., Yuan, D.-H., Zhao, J., Hong, H., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105922 · Cited by 19
Yuan, F., Zhou, Z., Wu, S., Jiao, F., Chen, L., Fang, L., Yin, H., Hu, X., Jiang, X., Liu, K., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215590120 · Cited by 21
Reviewing the neurobiology of electroconvulsive therapy on a micro- meso- and macro-level
Belge, J.-B., Mulders, P. C. R., van Diermen, L., Sienaert, P. A., Sabbe, B., Abbott, C., Tendolkar, I., Schrijvers, D. L., & van Eijndhoven, P. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110809 · Cited by 23
Fluoxetine promotes gliogenesis during neural differentiation in mouse embryonic stem cells
Kusakawa, S., Nakamura, K., Miyamoto, Y., Sanbe, A., Torii, T., Yamauchi, J., & Tanoue, A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22509 · Cited by 19
“Although SSRIs cause an acute increase in the amount of serotonin circulating in the brain (Manji et al., 2001), their clinical antidepressant effects usually become apparent only after a delay of several weeks.”
Yang, W., & Wang, H. (2016) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2016.10.016 · Cited by 19
“Depression is caused by reduction in the expression level of neurotransmitters which play a vital role in transmission of neuronal signals (Manji et al., 2001; Mathew et al., 2008).”
BackgroundBiotechnology, the brain and the future
Greenfield, S. A. (2004) · Trends in biotechnology · doi:10.1016/j.tibtech.2004.11.011 · Cited by 22
“... as the advances outlined here become a reality, and as the trend for high expectations of individual and society escalate [65], there willbeanincreasinglyblurreddistinctionbetween‘curing’a disease, and changing the type of thoughts and feelings an individualmightexperience.AlreadysomearetakingGinko bilobatoimprove…”
BackgroundProteomics of membrane receptors and signaling
Kabbani, N. (2008) · PROTEOMICS · doi:10.1002/pmic.200800139 · Cited by 23
What is effective treatment of depression in people with epilepsy?
Barry, J. J., & Jones, J. E. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.03.017 · Cited by 21
Fisiopatologia do transtorno afetivo bipolar: o que mudou nos últimos 10 anos?
Kapczinski, F. P., Frey, B. N., & Zanatto, V. C. (2004) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462004000700005 · Cited by 39
Dong, H., Cong, W., Guo, X.-W., Wang, Y., Tong, S., Li, Q., & Li, C. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8018 · Cited by 22
“Although the cause of depression is poorly understood, stress is considered to be the main contributing factor leading to biochemical alterations in the brain that present as the clinical symptoms of depression (4,5).”
RetractedNiziolek, G. M., Boudreau, R. M., Baker, J. E., Friend, L. A., Makley, A. T., Edwards, M. J., Gulbins, E., & Goodman, M. D. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6436 · Cited by 18
“Recently, decreased neurogenesis within the hippocampus has been proposed as a contributor to the pathogenesis of major depression.(50,51) In a murine model of depression, Asm inhibition was”
BackgroundWang, Y., Liu, L., Wang, Y., Wang, J., Gao, T., Wang, H., Chen, T., Guan, W., & Jiang, B. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.08.028 · Cited by 19
Medicinal Plants in the Treatment of Depression. II: Evidence from Clinical Trials
Moragrega, I., & Ríos, J. L. (2021) · Planta Medica · doi:10.1055/a-1517-6882 · Cited by 22
Socała, K., Nieoczym, D., Wyska, E., Poleszak, E., & Właź, P. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0756-9 · Cited by 18
“Although many experimental and clinical studies clearly implicated the involvement of monoamines in pathophysiology of depressive disorders, the monoaminergic hypothesis does not provide sufficient explanation for mechanism underlying depression and mode of action of antidepressant drugs (Manji et al. 2001; Krishnan a…”
p11 and Gene Therapy for Severe Psychiatric Disorders: A Practical Goal?
Chen, G., Twyman, R. E., & Manji, H. K. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001754 · Cited by 19
Self-citationA depression model of social defeat etiology using tree shrews
Wang, J., Zhou, Q., Lv, L., Xu, L., & Yang, Y. (2013) · Zoological Research · doi:10.3724/sp.j.1141.2012.01092 · Cited by 18
“…应激损伤至少占据了 50%的贡献(Cohen et al, 2007)。然而, 目前尚缺乏理想的动物模型能使我 们获得病因学的确切证据, 现阶段抑郁症的疾病模 型还有许多需要改进的地方。本文分析了多种抑郁 症疾病模型建立的方法和有效性, 对未来可能发 展的抑郁模型提出设想, 为新型模型的开发和完 善提供思路和方法,以期为更好地研究抑郁症提供 依据。 1 抑郁症机理与动物模型 1.1 抑郁症发生机理假说 至今抑郁症的发生机理仍然不清楚,…”
InfluentialChen, Y., Huang, L.-Y., Liao, W.-L., & Chou, P. (2019) · Journal of Ophthalmology · doi:10.1155/2019/2749296 · Cited by 18
Ahn, Y., Han, S., Kim, M. G., Hong, K., Kim, W. J., Suh, H. J., & Jo, K. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2021.1949356 · Cited by 22
“According to the monoamine hypothesis, deficiency of monoamine neuromodulators (serotonin, norepinephrine, and dopamine) in the central nervous system can lead to the development of depression (Manji et al. 2001).”
BackgroundAnalysis of Calcium Channels by Conditional Mutagenesis
Moosmang, S., Kleppisch, T., Wegener, J. W., Welling, A., & Hofmann, F. B. (2007) · Springer eBooks · doi:10.1007/978-3-540-35109-2_19 · Cited by 21
Weight loss dynamics during combined fluoxetine and olanzapine treatment
Perrone, J. A., Chabla, J. M., Hallas, B. H., Horowitz, J. M., & Torres, G. (2004) · BMC Pharmacology · doi:10.1186/1471-2210-4-27 · Cited by 18
“For instance, whereas fluoxetine and olanzapine alone activate several signaling pathways involved in cell survival and plasticity [8-10], drug augmentation therapy reduces the levels of certain transcription factors (e.”
BackgroundFrye, C. A., Paris, J. J., Osborne, D. M., Campbell, J. C., & Kippin, T. E. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00052 · Cited by 20
“In adults, and rodent models, depression is associated with decreased neurogenesis in dentate gyrus and increased plasma glucocorticoid formation (Manji et al., 2001; Sapolsky, 2001).”
BackgroundParsaei, L., Torkaman‐Boutorabi, A., Asadi, F., & Zarrindast, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.07.007 · Cited by 18
“It has been shown that lithium may increase GABA signaling (Manji et al., 2001), which can mediate lithium induced memory impairment.”
Dietary seaweed intake and depressive symptoms in Japanese adults: a prospective cohort study
Guo, F., Huang, C. X., Cui, Y., Momma, H., Niu, K., & Nagatomi, R. (2019) · Nutrition Journal · doi:10.1186/s12937-019-0486-7 · Cited by 18
Leistedt, S., Dumont, M., Coumans, N., Lanquart, J. ‐., Jurysta, F., & Linkowski, P. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.06.032 · Cited by 21
Norepinephrine activates extracellular-regulated kinase in cortical neurons
Tolbert, L. M., Russell, D., & Duman, R. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00346-9 · Cited by 19
Peripheral Biomarkers in Animal Models of Major Depressive Disorder
Carboni, L. (2013) · Disease Markers · doi:10.1155/2013/284543 · Cited by 20
“They comprise hypotheses based on monoaminergic deficiency, hypothalamicpituitary-adrenal (HPA) axis dysregulation, neurogeneticneurotrophic-growth factor impairment, metabolic disturbances, circadian rhythm desynchronization, and inappropriate stimulation of the immune system [18–20, 23–26].”
BackgroundMahesh, R., Bhatt, S., Devadoss, T., Jindal, A. K., Gautam, B., & Pandey, D. K. (2012) · Journal of Young Pharmacists · doi:10.4103/0975-1483.104367 · Cited by 19
“Depression is a chronic, recurring, and potentially life- threatening illness that affects up to 20% of the population across the globe.[1-4] It is one of the top ten causes of morbidity and mortality worldwide, based on Antidepressant Potential of 5-HT3 Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxami…”
Song, J. M., Xing, G., Cao, J., Teng, L., Li, C.-L., Meng, Q.-F., Lü, J., Zhou, Y., Liu, Y., Wang, D., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4584 · Cited by 18
“According to statistics, depression affects almost 15-25% of the world's population, and is expected to become the second largest global burden by 2020 (3).”
DHEA and polycystic ovarian syndrome: Meta-analysis of case-control studies
Benjamin, J. J., Kuppusamy, M., Koshy, T., Maruthy, K. N., & Padmavathi, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261552 · Cited by 21
Antidepressant Effect of Crocin in Mice with Chronic Mild Stress
Alsanie, W. F., Alamri, A. S., Abdulaziz, O., Salih, M. M., Alamri, A., Asdaq, S. M. B., Alhomrani, M. H., & Alhomrani, M. (2022) · Molecules · doi:10.3390/molecules27175462 · Cited by 21
“Monoamine neurotransmitter abnormalities [2], as well as enhanced oxidative and nitrosative damage [3], are the main mechanisms.”
BackgroundÄtiopathogenese der unipolaren Depression: Neurobiologische und psychosoziale Faktoren
Brakemeier, E., Normann, C., & Berger, T. (2008) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-008-0505-x · Cited by 45
Giubellina, N., Stabile, P., Laval, G., Perboni, A. D., Cimarosti, Z., Westerduin, P., & Cooke, J. W. B. (2010) · Organic Process Research & Development · doi:10.1021/op100103v · Cited by 21
Psychogeriatric Research: A Conceptual Introduction to Aging and Geriatric Neuroscience
Cacabelos, R. (2001) · Psychogeriatrics · doi:10.1111/j.1479-8301.2001.tb00046.x · Cited by 18
Chen, J., Newton, S. S., Zeng, L., Adams, D. H., Dow, A. L., Madsen, T. M., Nestler, E. J., & Duman, R. S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300289 · Cited by 19
“In addition, brain imaging studies have demonstrated a reduction of hippocampal volume in depressed patients (Manji et al, 2001; Nestler et al, 2002).”
BackgroundInfluentialLagatta, D. C., Fassini, A., Terzian, A. L. B., Corrêa, F. M. D. A., & Resstel, L. B. M. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-022-02786-5 · Cited by 20
Jin, F., Li, L., Shi, M., Li, Z., Zhou, J., & Chen, L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.02.029 · Cited by 20
Serres, F., Millan, M. J., & Sharp, T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000733 · Cited by 17
“…after administration of S35966 and venlafaxine has high relevance in the context of current theories linking changes in neural plasticity to depression and antidepressant action (Castren, 2005; D’Sa & Duman, 2002 ; Duman, 2002 ; Krishnan & Nestler, 2008; Manji et al. 2001; Mathew et al. 2008).”
BackgroundAnanth, M. R., DeLorenzo, C., Yang, J., Mann, J. J., & Parsey, R. V. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.189654 · Cited by 18
“The serotonergic system has been implicated in the pathophysiology of depression and is a major target of antidepressant treatment (7,8).”
BackgroundAmidfar, M., Kim, Y., Scaini, G., & Quevedo, J. (2018) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32623 · Cited by 16
Hansen, H. H., Rantamäki, T., Larsen, M. H., Woldbye, D. P. D., Mikkelsen, J. D., & Ċastrén, E. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9145-1 · Cited by 19
“The PFC is a key region implicated in the pathophysiology of depression (Manji et al., 2001), suggesting that TrkB activation in the PFC is an important mechanism for antidepressant action.”
BackgroundcRGD mediated liposomes enhanced antidepressant-like effects of edaravone in rats
Qin, J., Zhang, R., Li, J., Wang, J., Hou, J., Yang, X., Zhu, W., Shi, J., & Lü, L. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.03.006 · Cited by 16
Restorative therapies to enhance sensorimotor recovery following cerebral ischemia
Ortega, F. J., & Jolkkonen, J. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1922 · Cited by 18
“…production of neurotrophic factors, increases axonal sprouting and the production of new synapses, increases proliferation of glial precursor cells and even increases hippocampal neurogenesis (Malberg et al. 2000, Manji et al. 2001, Santarelli et al. 2003, Hashioka et al. 2007, Perera et al. 2007).”
BackgroundGilbert‐Ouimet, M., Trudel, X., Aubé, K., Ndjaboué, R., Duchaine, C. S., Blanchette, C., Mâsse, B. R., Vézina, M., Milot, A., & Brisson, C. (2020) · Occupational and Environmental Medicine · doi:10.1136/oemed-2019-106242 · Cited by 16
Lithium spectroscopic imaging of rat brain at therapeutic doses
Ramaprasad, S. (2004) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2004.01.063 · Cited by 18
Prospects for the Treatment of Depression
Norman, T. R. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01814.x · Cited by 21
“By implication the changes induced by chronic drug administration are believed to reverse deficits present in depression, but evidence for transmitter and receptor changes in patients is equivocal at best [5].”
BackgroundCichon, J., Joseph, T. T., Lu, X., Wasilczuk, A. Z., Kelz, M. B., Mennerick, S. J., Zorumski, C. F., & Nägele, P. (2025) · Nature Communications · doi:10.1038/s41467-025-57951-y · Cited by 17
Protective effects of butein on corticosterone-induced cytotoxicity in Neuro2A cells
Ohmoto, M., Shibuya, Y., Taniguchi, S., Nakade, T., Nomura, M., Ikeda‐Matsuo, Y., & Daikoku, T. (2020) · IBRO Reports · doi:10.1016/j.ibror.2020.02.002 · Cited by 15
“Prolonged glucocorticoid (GC) elevation due to chronic stress has been shown to reduce hippocampal volume and impair hippocampusdependent functions, leading to the development of depression (Nestler et al., 2002; Manji et al., 2001; Gould et al., 1998; Lupien et al., 1998).”
BackgroundNeural Mechanisms of Exercise: Effects on Gut Miccrobiota and Depression
Yuan, T., Rocha, N., Paes, F., Arias-Carrión, Ó., Machado, S. E. D. C., & Filho, A. S. S. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666151111124729 · Cited by 17
Zubenko, G. S., & Hughes, H. B. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.23 · Cited by 15
Differential effects of depressive symptoms on prospective and retrospective memory in old age
Livner, Å., Berger, A., Karlsson, S., & Bäckman, L. (2008) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390701380591 · Cited by 17
“Because depression is also associated with alterations in other brain areas, including frontal regions ( Drevets, 2000 ; Manji, Drevets, & Charney, 2001 ), the question arises whether the depression-related memory impairment also includes ProM.”
BackgroundThe Gem interacting protein (GMIP) gene is associated with major depressive disorder
Tadokoro, K., Hashimoto, R., Tatsumi, M., Kosuga, A., Kamijima, K., & Kunugi, H. (2005) · Neurogenetics · doi:10.1007/s10048-005-0003-3 · Cited by 17
“MDD has traditionally been considered to have a neurochemical basis, but recent studies have associated this complex disorder with volume reductions in brain structures and in the numbers and/or sizes of glia and neurons in discrete brain areas [12].”
ResultResidual symptoms in depression
Sonino, N., & Fava, G. A. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00200-2 · Cited by 23
Pruus, K. (2006) · DSpace repository (University of Tartu) · Cited by 15
ZHONG, J.-M., WU, S.-Y., BAI, J., GUO, Q., TAO, J., CHEN, H., ZHAO, N.-W., ZHAO, Z., & FU, H. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.669 · Cited by 14
“It has been widely reported that depression is a consequence of diminished neurotransmission due to a decrease in neurotransmitter concentrations (25,26).”
BackgroundJawad, M. Y., Fatima, M., Hassan, U., Zaheer, Z., Ayyan, M., Ehsan, M. T., Khan, M. H. A., Qadeer, A., Gull, A. R., Asif, M. T., et al. (2023) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2871 · Cited by 17
“Overall, these findings suggest that the acute administration of SSRIs may affect emotional processing even before antidepressant or anxiolytic effects are observed (Manji et al., 2001).”
BackgroundParsaei, L., Rangchiyan, M., Ahmadi, S., & Zarrindast, M. (2011) · PubMed Central · Cited by 16
Topic, B., Oitzl, M. S., Meijer, O. C., Huston, J. P., & Silva, M. A. D. S. (2008) · Neuropsychobiology · doi:10.1159/000182890 · Cited by 15
“differences between patients with early versus late-onset depression. However, studies examining the underlying neuropathology of depressive-like behavior in the aged, especially in rodents, are sparse and new animal models are needed to cover the various aspects of the disease.A number of imbalances and/or abnormalit…”
BackgroundNeurodegeneration, β‐amyloid and mood disorders: state of the art and future perspectives
Piccinni, A., Origlia, N., Veltri, A., Vizzaccaro, C., Marazziti, D., Vanelli, F., Moroni, I., Domenici, L., & Dell’Osso, L. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3879 · Cited by 16
“This includes different homologous proteins, such as the brainderived neurotrophic factor (BDNF), involved in differentiation, survival of peripheral and central neurons and modulation of synaptic plasticity (Manji et al., 2001; Poo, 2001; Popoli et al., 2002).”
BackgroundMood dysregulation and stabilization: perspectives from emotional cognitive neuroscience
Yamawaki, S., Okada, G., Okamoto, Y., & Liberzon, I. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000757 · Cited by 17
Cholinergic Treatment of Traumatic Brain Injury
Tenovuo, O. S. (2006) · Current Drug Therapy · doi:10.2174/157488506776930932 · Cited by 16
“Theoretically, depressive patients might respond less than others [333], why some measure of depression should be included.”
BackgroundSuicidal Behavior and Its Relationship with Postmortem Forensic Toxicological Findings
Collados-Ros, A., Torres-Sánchez, C., Pérez-Cárceles, M. D., Luna, A., & Legaz, I. (2022) · Toxics · doi:10.3390/toxics10060319 · Cited by 13
“The role of signal transduction and molecular systems in medicated patients with major depression or drug abuse and/or suicidal behavior is being investigated [29,30].”
BackgroundTakagi, K., Tanahashi, N., Amagasu, N., Mizuno, K., Kawanokuchi, J., Guo, Y., & Ishida, T. (2016) · Journal of Acupuncture and Meridian Studies · doi:10.1016/j.jams.2016.11.006 · Cited by 13
“A theory that has gained attention in recent years is the neural plasticity hypothesis [5 e 7].”
da Silva, M. D., Guginski, G., Sato, K., Sanada, L. S., Sluka, K. A., & Santos, A. R. S. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100118 · Cited by 15
Foell, J., Klawohn, J., Bruchnak, A., Brush, C. J., Patrick, C. J., & Hajcak, G. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111298 · Cited by 16
Massardo, T., Quintana, J. C., Risco, L., Corral, S. A., Spuler, J., Vicentini, D., Castro-Muñoz, G., Riedel, B., Villa, C., & Pereira, J. I. (2022) · Neuropsychobiology · doi:10.1159/000521104 · Cited by 13
Effects of psychotropic drugs on brain plasticity in humans
Paulzen, M., Veselinović, T., & Gründer, G. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139004 · Cited by 14
“The monoamine hypothesis was therefore extended to a ‘chemical hypothesis’ (Manji et al., 2001) proposing that mood disorders are caused by structural or functional changes in particular molecules of the brain (Castrén, 2005).”
Swann, G., Byck, G. R., Dick, D. M., Alıev, F., Latendresse, S. J., Riley, B. P., Kertes, D. A., Sun, C., Salvatore, J. E., Bolland, J. M., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.020 · Cited by 15
“Past research has found a complex etiology for depression that encompasses multiple neurotransmitter systems, including opioids, and structures of the brain (Manji et al., 2001).”
Rajkumar, R., & Mahesh, R. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777256 · Cited by 15
“While arriving at the molecular and cellular hypothesis of depression behind the apparent neurotransmitter theory, several composite intracellular mechanisms [188] which amplify the neurotrophic factors [75,294] eventually regulate the life, structure and functioning of neurons [76].”
BackgroundDepression: Phenomenology, Epidemiology, and Pathophysiology
Nihalani, N. D., Simionescu, M., & Dunlop, B. W. (2009) · Medical psychiatry · doi:10.3109/9781420084887.001 · Cited by 21
Gao, Y., Yao, Y., Liang, X., Tang, J., Ma, J., Qi, Y., Huang, C., Zhang, Y., Chen, L., Chao, F., et al. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.11.013 · Cited by 13
Genetic Variation Associated With Depressive Symptoms in Breast Cancer Patients: A Systematic Review
Bayer, S. J., Yang, G. S., & Lyon, D. (2020) · Cancer Nursing · doi:10.1097/ncc.0000000000000903 · Cited by 14
“Met allele carriers may be vulnerable to depressive symptoms due to lower levels of BDNF,(34) which is a neurotrophin mostly found in the brain and shows neuroprotective effects such as antidepressants.(35) Colle et al(34) studied the relationship among the BDNF Val66Met polymorphism, plasma BDNF levels, and clinical…”
BackgroundGrabowska, K., Ziemichód, W., & Biała, G. (2023) · Brain Sciences · doi:10.3390/brainsci13010121 · Cited by 14
“Studies conducted on laboratory animals in the CMUS model revealed that chronically acting stressors cause atrophy of the hippocampus pyramidal cells of the CA3 area and cause a decrease in resistance to other damaging factors (hypoglycemia, hypoxia) [48].”
BackgroundNahas, Z. H., JIANG, Y., Zeidan, Y. H., Bielawska, A. E., Szulc, Z. M., DeVane, L., Kalivas, P. W., & Hannun, Y. A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.07.040 · Cited by 12
Assareh, N., ElBatsh, M. M., Marsden, C. A., & Kendall, D. A. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.017 · Cited by 12
“Additional evidence indicates that cannabinoid compounds also affect the HPA axis (Manji et al., 2001).”
BackgroundCellular plasticity and resilience and the pathophysiology of severe mood disorders
Charney, D. S., DeJesus, G., & Manji, H. K. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.2/dcharney · Cited by 16
Self-citationYang, Y., Ang, W., Long, H., Chang, Y., Li, Z., Zhou, L., Yang, T., Deng, Y., & Luo, Y. (2016) · Scientific Reports · doi:10.1038/srep34711 · Cited by 15
Botanas, C. J., Custodio, R. J. P., Kim, H. J., de la Peña, J. B., Sayson, L. V., Ortiz, D. M., Kim, M., Lee, H. J., Acharya, S., Kim, K., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108619 · Cited by 14
- Role of the Endocannabinoid System in the Neurobiology of Suicide
Dwivedi, Y. (2012) · CRC Press eBooks · doi:10.1201/b12215-11 · Cited by 12
Magnetic resonance spectroscopic imaging studies of lithium
Ramaprasad, S. (2005) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2005.07.001 · Cited by 12
Neurobiology and Treatment of Anxiety: Signal Transduction and Neural Plasticity
Duman, C. H., & Duman, R. S. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_11 · Cited by 15
“…drugs are effective upon chronic, but not after acute administration for the treatment of both depression and anxiety, suggesting that drug-induced plasticity may contribute to the effectiveness of these drugs in both types of affective disorders (Duman et al. 2000; Manji et al. 2001).”
BackgroundDu, J., Quiroz, J. A., Gray, N. A., Szabo, S. T., Zarate, C. A., & Manji, H. K. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.2/jdu · Cited by 13
“Consequently, recent evidence demonstrating that impairments of neuroplasticity may underlie the pathophysiology of mood disorders, and that antidepressants and mood stabilizers exert major effects on the signaling pathways that regulate cellular plasticity and resilience, have generated considerable excitement among…”
BackgroundSelf-citationKetter, T. A., & Drevets, W. C. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00043-9 · Cited by 15
Self-citationBobula, B., Tokarski, K., Zahorodna, A., & Hess, G. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0744-1 · Cited by 12
“This ‘therapeutic lag’ has been linked to the development of adaptive changes in the brain serotonergic system as well as in other neurotransmitter systems, however, cellular mechanisms of these adaptive modifications remain largely unknown (reviewed in: Skolnick 1999; Vetulani and Nalepa 2000; Manji et al. 2001 ).”
BackgroundZhang, X., Wang, X., Dong, D., Sun, X., Zhong, X., Xiong, G., Cheng, C., Lei, H., Chai, Y., Yu, M., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.09.003 · Cited by 11
Hajmirzaeyian, A., Chamanara, M., Rashidian, A., Shakyba, S., Nassireslami, E., & Akhavan‐Sigari, R. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e05900 · Cited by 11
“The pivotal role of NMDA receptors in the pathophysiology of mood and affective disorders has been confirmed by several lines of research (Manji et al., 2001).”
BackgroundRudra, S., Faruque, M. O., Tahamina, A., Emon, N. U., Haidar, I. K. A., & Uddin, S. B. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.04.027 · Cited by 15
“affected by depression, which is a crippling and potentially fatal illness (Manji et al., 2001; Charney, 2004).”
Fluoxetine Up-Regulates Bcl-xL Expression in Rat C6 Glioma Cells
Choi, M., Oh, D. H., Kim, S. H., Yang, B., Lee, J., Choi, J., Jeon, H.-S., Chai, Y. G., & Park, Y. C. (2011) · Psychiatry Investigation · doi:10.4306/pi.2011.8.2.161 · Cited by 12
Río, J. D., & Frechilla, D. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_10 · Cited by 11
Kędzierska, E., Fiorino, F., Magli, E., Poleszak, E., Właź, P., Orzelska‐Górka, J., Knap, B., & Kotlinska, J. H. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01620-7 · Cited by 11
Quiroz, J. A., & Manji, H. K. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.1/jquiroz · Cited by 12
“The brain systems that have heretofore received the greatest attention in neurobiological studies of major depressive disorder (MDD) are the monoaminergic neurotransmitter systems, which are extensively distributed throughout the network of limbic, striatal, and prefrontal cortical neuronal circuits thought to support…”
BackgroundSelf-citationPryce, C. R., Rüedi‐Bettschen, D., Dettling, A. C., & Feldon, J. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80048-3 · Cited by 13
Zubenko, G. S., & Hughes, H. B. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30708 · Cited by 11
“Among its target genes, CP2 appears to regulate the expression of glycogen synthase kinase 3b [Lau et al., 1999], which has been implicated in the pathophysiology of both mood disorders and AD [Manji et al., 2001; Bhat et al., 2004; Jope et al., 2007].”
BackgroundAssociation between major depressive disorder and subsequent tinnitus: A population-based study
Kao, L., Shih, J., Yeh, C., Wang, C., Chen, H., Chien, W., & Li, I. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.141 · Cited by 12
Taoka, H., Hamamura, T., Endo, S., Miki, M., Lee, Y., Miyata, S., Toma, K., Ishihara, T., Sagara, H., Gomita, Y., et al. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.01.033 · Cited by 11
Kroll, T., Grözinger, M., Matusch, A., Elmenhorst, D., Novakovic, A. M., Schneider, F. W., & Bauer, A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1228438 · Cited by 10
“The neurobiological understanding of mood disorders has shifted its focus some 20 years ago from monoaminergic transmission to neural plasticity and resilience (2, 3).”
BackgroundYang, J., Wang, S., Zhang, Z., Huang, J., Chen, W., & Xu, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39245 · Cited by 10
Acupuncture Treatment for Social Defeat Stress
Kawanokuchi, J., Takagi, K., Tanahashi, N., Yamamoto, T., Nagaoka, N., Ishida, T., & Ma, N. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.685433 · Cited by 11
The endocannabinoid system: critical for the neurotrophic action of psychotropic drugs
Hassanzadeh, P. (2010) · Biomedical Reviews · doi:10.14748/bmr.v21.45 · Cited by 10
Metadata
- Authors
- Manji, H. K., Drevets, W. C., & Charney, D. S.
- Affiliations
- National Institutes of Health (US)
- National Institute of Mental Health (US)
- Corresponding author
- Manji, Husseini K.
- Venue
- Nature Medicine
- Published
- 2001-05
- Volume
- 7
- Issue
- 5
- Pages
- 541-547
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1509868652
- Cited by
- 1,182
- References
- 66
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 20 · 2023: 21 · 2022: 33 · 2021: 55 · 2020: 29 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 36 · 2015: 51 · 2014: 50 · 2013: 60 · 2012: 60
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, neurobiology of depression, neuroplasticity, cell survival, signaling pathways
- MeSH terms
- Antidepressive Agents, Cell Survival, Depressive Disorder, Glucocorticoids, Neuronal Plasticity, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.